US, EU Regulatory Approvals for New Orthofix Bone Growth Stimulators

Orthofix (OFIX) announced FDA premarket approval and European CE Mark approval for next-generation CervicalStim™ and SpinalStim™ bone growth stimulators. U.S. availability will include the Stim onTrack™ mobile app to support patient engagement and real-time delivery of data to the physician.

The Class III devices employ low-level pulsed...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us